SYMBOL: GMTX
Company: Gemini Therapeutics, Inc. /DE
Company: Gemini Therapeutics, Inc. /DE
SYMBOL
: GMTXStage: 5. Merger Complete
Size: $643.741.137
Latest Price: $14,21
Previous close: $13,99
All time high price: $14,84
Volume: 246.476
Average volume: 220.114
FOLLOW SPAC
DISCOVER NEW FRIENDS
GET AHEAD OF THE GAME
Gemini Therapeutics, Inc. /DE is listed on the stock exchange with the ticker / Symbol GMTX,
GMTX SPAC all time high was $14,84 and the lowest price in the last 52 week was: ,
the current GMTX stock price is $14,21. GMTX has an overall market cap of: $643.741.137.
The latest volume was: 246.476.
GMTX is currently in stage: 5. Merger Complete.
You can read all about GMTX and it’s information about the SPAC, news, SEC filings and more on our special data platform.
Want to know more about GMTX and Gemini Therapeutics, Inc. /DE? Join us today.
GMTX SPAC all time high was $14,84 and the lowest price in the last 52 week was: ,
the current GMTX stock price is $14,21. GMTX has an overall market cap of: $643.741.137.
The latest volume was: 246.476.
GMTX is currently in stage: 5. Merger Complete.
You can read all about GMTX and it’s information about the SPAC, news, SEC filings and more on our special data platform.
Want to know more about GMTX and Gemini Therapeutics, Inc. /DE? Join us today.
- Conduent Inc (CNDT) CEO Clifford Skelton Bought $100,206 of Shares – Yahoo Finance
- Adamas Pharmaceuticals: Q4 Earnings Insights – Yahoo Finance
- The Daily Biotech Pulse: Aridis To Study Antibody Cocktail For Coronavirus Variants, Revance & Protalix Data Readouts – Yahoo Finance
- 3 of the Latest Companies to Go Public Via SPACs – Investorplace.com
- Foresite Capital's SPAC FS Development II prices further upsized $175 million IPO – Nasdaq
- Ex-Vividion chief Diego Miralles finds 'dream team' at stealthy Flagship portfolio company; Astellas looks inward to select CBO and CSO – Endpoints News
- Gemini Therapeutics Debuts as Publicly Traded Precision Medicine Company Focused on Age-Related Macular Degeneration – Business Wire
- Biotech Gemini Therapeutics sinks 7.6% on first trading day – Seeking Alpha
- Gemini Therapeutics Hits the Nasdaq Following SPAC Merger – BioSpace
- DEADLINE: Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against GoodRx Holdings, Inc. – GDRX – Benzinga
- Supportive Care in Cancer – Comprehensive Overview, Pipeline Products, Research and Development Strategies and Unmet Needs – Yahoo Finance UK
- 3 ways I’m looking to profit from the renewable energy shares boom – Yahoo Finance UK
- LA County restricts in-person dining due to COVID-19 cases – Yahoo Canada Finance
- Our Exclusive Articles – Benzinga
[finviz ticker=GMTX]